Paid Clinical Trials Rockville

Discover 2,152 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,152

Danvatirsen & PembrolizumabActivity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Recruiting

PHASE2

Sponsor:

Flamingo Therapeutics NV

Location:

Baltimore MD, Morristown NJ, New York NY, Stony Brook NYshow 16 more

Code:

NCT05814666

Conditions

HNSCC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Danvatirsen

Pembrolizumab

Pembrolizumab with GemcitabineTesting the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Washington DC, Glen Burnie MD, Allentown PA, Bethlehem PAshow 257 more

Code:

NCT04164082

Conditions

Bladder Flat Urothelial Carcinoma In Situ

Non-Muscle Invasive Bladder Urothelial Carcinoma

Stage 0a Bladder Cancer AJCC v8

Stage 0is Bladder Cancer AJCC v8

Stage I Bladder Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Cystoscopy

Gemcitabine Hydrochloride

Lutetium Lu 177 DotatateTesting the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Baltimore MD, Winston-Salem NC, Columbus OH, Lexington KYshow 7 more

Code:

NCT05691465

Conditions

Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation

Metastatic Prostate Neuroendocrine Carcinoma

Metastatic Prostate Small Cell Neuroendocrine Carcinoma

Stage IV Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Gallium Ga 68-DOTATATE

Lutetium Lu 177 Dotatate

Positron Emission Tomography

RLS-0071Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Recruiting

PHASE2

Sponsor:

ReAlta Life Sciences, Inc.

Location:

Glen Burnie MD, Philadelphia PA, Saint Petersburg FL, Omaha NE

Code:

NCT06175065

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

RLS-0071

Placebo

AnticoagulationAnticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting

PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Bethesda MD, Falls Church VA, Washington DC, Baltimore MDshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

CoccidioidomycosisPathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis

Recruiting

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Bethesda MD

Code:

NCT02190266

Conditions

Coccidioidomycosis

Eligibility Criteria

Sex: All

Age: 2 - 70+

Healthy Volunteers: Not accepted

Genomic SequencingUncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing

Recruiting

Sponsor:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Location:

Bethesda MD

Code:

NCT06749366

Conditions

Enchondromatosis

Eligibility Criteria

Sex: All

Age: 2 - 70+

Healthy Volunteers: Not accepted

LurbinectedinStudy of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Recruiting

PHASE1

PHASE2

Sponsor:

Jazz Pharmaceuticals

Location:

Washington DC, Baltimore MD, Philadelphia PA, New York NYshow 11 more

Code:

NCT05734066

Conditions

Refractory Ewing Sarcoma

Relapsed Ewing Sarcoma

Ewing Sarcoma

Eligibility Criteria

Sex: All

Age: 2 - 30

Healthy Volunteers: Not accepted

Interventions

Lurbinectedin

Rinatabart SesutecanRinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Recruiting

PHASE1

PHASE2

Sponsor:

Genmab

Location:

Rockville MD, Fairfax VA, Doylestown PA, Norfolk VAshow 26 more

Code:

NCT05579366

Conditions

Platinum-Resistant Ovarian Cancer

Platinum Sensitive Ovarian Cancer (PSOC)

High Grade Epithelial Ovarian Cancer

High Grade Serous Ovarian Cancer

Primary Peritoneal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rina-S

Carboplatin

Bevacizumab

Pembrolizumab

LP352A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

Recruiting

PHASE3

Sponsor:

Longboard Pharmaceuticals

Location:

Bethesda MD, Morristown NJ, Livingston NJ, New York NYshow 22 more

Code:

NCT06908226

Conditions

Developmental and Epileptic Encephalopathy

Eligibility Criteria

Sex: All

Age: 2 - 66

Healthy Volunteers: Not accepted

Interventions

LP352